Issue Date: October 22, 2012
Eisai Focuses On Personalized Medicine
Japan’s Eisai will dissolve a 10-year-old subsidiary as part of a strategy to increase its focus on personalized medicine. Tokyo-based Palma Bee’Z Research Institute, a diagnostics R&D unit of Eisai, will be absorbed into a restructured and refocused Eisai R&D organization. Set up in 2002, Palm Bee’Z focuses on diagnostics that apply gene signal amplification technology discovered in-house.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society